SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-007115
Filing Date
2020-01-27
Accepted
2020-01-27 16:04:34
Documents
2
Period of Report
2020-01-23

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4161
2 EX-24 ex-24.htm EX-24 8492
  Complete submission text file 0001104659-20-007115.txt   14149
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Issuer) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ENTASIS THERAPEUTICS HOLDINGS INC. 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address
Tommasi Ruben (Reporting) CIK: 0001751824 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38670 | Film No.: 20549575